This study compared CRC specific survival (CSS) between patients by f-Hb concentration and referral priority in a large primary care f-Hb prioritised lower GI symptomatic pathway.<h4>Methods</h4>Retrospective single health board study of symptomatic patients submitting FIT in primary care, 2019-2022. This evidence concerns the gene GSTM1 and colorectal carcinoma.